Pacific Biosciences of California (PACB) USD0.0001

Sell:$1.34Buy:$1.35Price decreased$0.01 (0.74%)

NASDAQ:Price increased0.18%
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.34
Buy:$1.35
Change:Price decreased$0.01 (0.74%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$1.34
Buy:$1.35
Change:Price decreased$0.01 (0.74%)
Market closed |
Prices delayed by at least 15 minutes

Company Information

About this company

Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops, and manufactures sequencing solutions. Its products and technology include HiFi long-read sequencing technology, which addresses a set of applications including human germline sequencing, plant and animal sciences, infectious disease, microbiology, oncology, and other applications. Its sequencing technology supports oncology research by enabling analysis of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), providing researchers with insight into cancer biology. It focuses on creating sequencing systems to provide customers with a view of genomes, transcriptomes, and epigenomes. Its customers include academic and governmental research institutions, commercial testing and service laboratories, genome centers, public health labs, hospitals and clinical research institutes, contract research organizations (CROs), pharmaceutical companies, and agricultural companies.

Key people

John F. Milligan
Independent Chairman of the Board
Christian O. Henry
President, Chief Executive Officer, Director
Jim R. Gibson
Chief Financial Officer, Principal Financial and Accounting Officer
Mark Van Oene
Chief Operating Officer
Christopher Gibson
Director
William W. Ericson
Independent Director
Randall S. Livingston
Independent Director
Marshall L. Mohr
Independent Director
Click to see more

Key facts

  • Shares in issue
    302.00m
  • EPIC
    PACB
  • ISIN
    US69404D1081
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • Market cap
    $407.70m
  • Employees
    485
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.